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Over the last several years, four different phages of chlamydiae, in addition to a phage associated with
Chlamydia psittaci isolated from an ornithosis infection in ducks over 25 years ago, have been described and
characterized. While these phages and their chlamydial host specificities have been characterized in vitro,
there is virtually nothing known about the interaction of the phage with chlamydiae in their natural animal
host. CPG1 is a lytic phage specific for “Chlamydia caviae,” which is a natural parasite of the guinea pig. In
this study, guinea pigs were inoculated in the conjunctiva with suspensions of CPG1 and C. caviae and the
effect on the development of pathology and on the course of chlamydial infection in the conjunctiva was
determined. The presence of phage delayed the appearance of the peak level of chlamydiae in the animal and
decreased the pathological response. Evidence for replication of the phage in C. caviae in the conjunctival tissue
was observed. Modifying the ratio of phage to chlamydiae altered the course of infection and affected phage
replication. There was no evidence for the phage increasing the virulence of C. caviae infection.
Over the last several years, four different phages of chlamyd-
iae, in addition to a phage associated with Chlamydia psittaci
isolated from an ornithosis infection in ducks over 25 years ago
by Richmond and coworkers (22), have been described and
characterized. Hsia et al. isolated phage CPG1 from in vitro-
cultured “Chlamydia caviae,” the agent of guinea pig inclusion
conjunctivitis (7, 8). This was followed shortly thereafter by the
isolation of phages Chp2 (2) and CPO1 (R.-C. Hsia and P. M.
Bavoil, unpublished data) from Chlamydia abortus, AR39/
Cpn1 from Chlamydia pneumoniae (10, 18), and Chp3 from
Chlamydia pecorum (3). The chlamydiaphages belong to a class
of lytic phages that include the closely related Bdellovibrio
bacteriovorus phage pMH2K (1) and the Spiroplasma mel-
liferum phage SpV4 (21) and for which the single-stranded
DNA coliphage X174 is the prototype (4). The chlamydial
host range for the various chlamydiaphages is varied, but all
are lytic for their respective hosts; however, it is interesting to
note that chlamydiaphages have not yet been detected in associ-
ation with Chlamydia trachomatis or Chlamydia muridarum.
That five different chlamydiaphages have been described for
chlamydiae infecting different animal species from geographi-
cally distinct areas would suggest that they are prevalent in
chlamydiae in nature. Nevertheless, because all of the chlamy-
diaphages have been isolated from chlamydiae in tissue culture
and their interaction with their hosts has been characterized
from tissue culture, there is literally nothing known about the
interaction of the chlamydiaphages with their bacterial hosts in
the context of infection of the natural hosts of the bacteria. In
fact, there are no data describing the interaction of any bac-
teriophage of an obligate intracellular bacterium in the natural
animal host of the bacterium.
It is indeed fortunate that CPG1 has been isolated from C.
caviae since C. caviae is a natural parasite of the guinea pig and
a model for both chlamydial ocular and genital tract diseases.
This presents the opportunity to evaluate the role of chlamy-
diaphage in the pathogenesis of chlamydial infection in vivo.
While phage-bearing strains of bacteria have often been found
to be more virulent than the same strains without phage be-
cause of the presence of virulence genes in the phage, there is
no evidence to date of any genes associated with the CPG1
genome that impact chlamydial pathogenicity. Moreover, since
the current strains of C. caviae were isolated from guinea pigs
over 40 years ago (12), there is no published evidence for the
detection of CPG1 in vivo in the animal host. Thus, in this
study, we undertook to determine the effect of chlamydiaphage
infection of C. caviae on the course of chlamydial conjunctival
infection in the guinea pig model and to determine the viability
and infection kinetics of the chlamydiaphage in the conjuncti-
val tissue.
MATERIALS AND METHODS
Propagation of chlamydiae. C. caviae cultured in the Rank laboratory at the
University of Arkansas for Medical Sciences (UAMS) was originally obtained
from the late Edward Murray as a direct passage of the original isolate from
guinea pigs (12) and has been continuously passaged since that time. This stock
has been found to be phage free when evaluated by PCR for the gene encoding
the major capsid protein, VP1. In fact, it should be noted that the original
passage (passage 1) in Murray’s laboratory from guinea pigs in 1962 (12), ob-
tained from the late Bruce MacDonald, was also found to lack the phage. C.
caviae for infection purposes was grown in McCoy cells, and stocks were pre-
pared according to previously described techniques (5). Only phage-free C.
caviae was grown in the UAMS laboratory.
Propagation of chlamydiaphage. All chlamydial stocks containing phage were
grown in the Bavoil laboratory at the University of Maryland and sent to UAMS
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for direct inoculation into guinea pigs without further manipulation. CPG1
phage was originally isolated from C. caviae cultured from guinea pigs by Julius
Schachter (6). This C. caviae isolate was a distinct isolate from guinea pigs and
was obtained from Schachter in 1987 and maintained in the Bavoil laboratory.
When it became apparent that the Schachter C. caviae was infected with CPG1,
the Murray strain of C. caviae was given to P. M. Bavoil in 1993 by R. G. Rank.
All of the subsequent phage culture has been performed with the Murray C.
caviae isolate. Thus, the Murray C. caviae strain has been maintained separately
in the Rank and Bavoil laboratories since that time.
C. caviae/phage culture lysates were prepared mostly as previously described
(6). Briefly, 10 plates of confluent HeLa cells were infected with 6.4  107
inclusion-forming units (IFU) of phage-free C. caviae preinfected with a CHCl3-
treated C. caviae phage lysate in sucrose-phosphate-glutamic acid (SPG) buffer.
After incubation for 2 h with intermittent rocking at room temperature, Dul-
becco’s modified Eagle medium was added, and incubation continued for 11 days
at 37°C in 5% CO2. The resulting C. caviae/phage culture lysate is highly en-
riched for phage but also contains 106 IFU/ml of C. caviae because not all of the
chlamydiae become infected. Purified phage was obtained upon treatment of C.
caviae/phage culture lysates with chloroform (1:1). The chloroform suspension
was immediately centrifuged at 10,000  g at 4°C for 5 min, and the aqueous
layer was transferred into a clean tube. This suspension was again centrifuged in
order to remove the remaining chloroform.
Inoculation of guinea pigs. Female Hartley strain guinea pigs (Charles River
Laboratories), weighing 500 to 550 g, were inoculated ocularly by depositing 25
l of inoculum on the eye and lifting the conjunctiva to allow the fluid to contact
the inner conjunctival surface. Groups of five animals each were inoculated in
both eyes with 106 IFU of phage-free C. caviae (Rank laboratory), C. caviae/
phage culture lysates (Bavoil laboratory), or phage alone. Animals receiving
phage alone were inoculated with CHCl3-treated C. caviae CPG1 lysate. The C.
caviae/phage culture lysate from the Bavoil laboratory was used only in the first
experiment (see Fig. 1). Thereafter, in the following experiments, all C. caviae
and phage combinations used C. caviae from the Rank laboratory.
Assessment of infection. Conjunctival material for the isolation and quantifi-
cation of chlamydiae was collected from the conjunctiva using a Dacron swab and
then placing the swab in 2-sucrose-phosphate transport medium (23). The swabs
were processed for isolation and determination of number of IFU by standard
techniques (13).
Quantitative PCR for phage detection. Because CPG1 is a phage of an
obligate intracellular bacterium, standard methodology for the quantification of
phages of other bacteria could not be applied here. A separate swab was col-
lected and placed in 1 ml of SPG buffer to determine the amount of phage
genomic DNA. Ten microliters of this suspension was processed directly for
preparing DNA with Sigma Extract-N-Amp blood PCR kits. The processed
sample (2.5 l) was used for quantitative PCR in a reaction mixture containing
0.4 M of each primer and probe in a 12.5-l reaction volume containing iQ
supermix (Bio-Rad). The primers used for amplifying CPG1 are Hex-AGCCT
CTGTACGCGCCGATCTCAAC-BHI (Probe), AAGTCTTTCACAGAACAT
GGTGTAA (Forward), and CTTCGTGACCACATCCTATCCA (Reverse). No
Alexa Fluor dyes or quencher was used. Quantitative PCR was carried out using
iQ supermix in a Bio-Rad iCycler, following the protocol of 95°C denaturation
for 3 min, followed by 40 cycles of 95°C (30 s) and 60°C annealing (1 min). A
standard curve was generated with recombinant phage DNA (plasmid pCpG1)
(7). Absolute concentrations of DNA obtained from PCR were extrapolated to
entire swabs for representation in figures. These primers do not amplify the
residual phage DNA which is incorporated in the C. caviae genome.
Assessment of pathological response. Gross pathological changes in the con-
junctiva were evaluated daily following inoculation. Both eyes from each animal
were observed, and the score was recorded; thus, the pathology score repre-
sented the mean of 10 conjunctiva in each group. There was generally very good
agreement in the scores from both eyes in individual animals. The changes were
assessed on a scale of 0 to 4 as previously described (16). Briefly, palpebral and
bulbar conjunctivas were evaluated for erythema, edema, and exudation. The
scores were defined as follows: slight erythema or edema of either the palpebral
or bulbar conjunctiva, 1; definite erythema or edema of either the palpebral
or bulbar conjunctiva, 2; definite erythema or edema of both the palpebral and
bulbar conjunctivas, 3; definite erythema or edema of both the palpebral and
bulbar conjunctivas and the presence of exudate, 4.
Antibody response. Terminal bleeds were obtained from each animal, and the
presence of antibody to the VP1 protein of CPG1 was determined by immu-
noblot analysis. VP1 (the major capsid protein) is the most abundant phage
protein, is a potent immunogen, and is considered immunodominant in the
context of infection. Briefly, Escherichia coli BL21 cells carrying pET30aVP123
or pET30a were loaded on a 10% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis gel and transferred to polyvinylidene difluoride membranes
(Amersham Pharmacia Biosciences). Immune sera from CPG1-infected C.
caviae-infected guinea pigs were preadsorbed with lysates of E. coli
BL21(pET30a) to remove nonspecific antibody (not shown). Membranes were
blotted with the preadsorbed sera diluted 1:100, followed by alkaline phos-
phatase-conjugated donkey anti-guinea pig immunoglobulin G polyclonal anti-
body (Chemicon). The blots were visualized with ECF (Amersham Pharmacia
Biosciences) and read using ImageQuant 5.2 (Amersham Biosciences).
Statistical analyses. Since all experiments recorded repeated measures from
individual animals, statistical significance was determined by a two-factor (group,
days) analysis of variance with repeated measures on one factor (days). Differ-
ences were considered to be significant if P was 0.05.
RESULTS
Because there is no information available on the relative
numbers of phage particles associated with chlamydial infec-
tion in vivo, we arbitrarily decided to first inoculate animals
with the C. caviae/phage culture lysate (Bavoil laboratory). The
lysate contained approximately 106 IFU/ml of chlamydiae and
51.44 g/ml of VP1 DNA, as determined by quantitative PCR.
As controls, groups were inoculated with 106 IFU of C. caviae
or chlamydiaphage alone. Each experimental group contained
five guinea pigs. The chlamydiaphage alone was derived from
an aliquot of the C. caviae/phage culture lysate. A large
amount of phage DNA was lost in the purification process so
that the chlamydiaphage inoculate contained 4.14 g/ml of
VP1 DNA.
The gross pathological response was assessed at various
times after inoculation. The conjunctivas inoculated with phage-
free C. caviae began to develop pathology by 2 days after
inoculation and reached a peak response by 4 days, but pathol-
ogy subsided thereafter and finally resolved by 12 days after
inoculation (Fig. 1A). In contrast, the ocular response in ani-
mals inoculated with the C. caviae/phage culture lysate was
significantly different from the control (P  0.001 according to
a two-factor [group, days] analysis of variance with repeated
measures). There was a significant delay in the onset of the
pathological response in animals inoculated with the C. caviae/
phage culture lysate, with conjunctivitis first being detected 5
days after inoculation. The response peaked at 6 days but did
not achieve the same level of intensity as that for the control
phage-free C. caviae preparation. No gross pathology at any
time was observed in animals inoculated with chlamydiaphage
alone, indicating that any residual C. caviae was not infectious
or that the dose was below the 50% infectious dose (48 IFU)
for C. caviae in the eye.
The courses of C. caviae infection in both groups of animals
were evaluated by the culture of conjunctival swabs collected
every 3 days. Because the C. caviae inoculum was relatively
high, the level of IFU in the phage-free C. caviae group
reached high levels very quickly and then gradually diminished
until day 21 (Fig. 1B). The infection in guinea pigs inoculated
with the C. caviae/phage culture lysate was significantly differ-
ent from that in the control group (P 0.001), increasing more
slowly and peaking 3 days later than that in the control group,
although both groups resolved their infections similarly. Thus,
it was apparent that the presence of the phage modified the
course of chlamydial ocular infection and also reduced the
pathological response to C. caviae.
In order to determine whether CPG1 was able to replicate
in vivo, the amount of phage DNA was quantified from the
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conjunctival swabs by quantitative PCR. Comparable to chla-
mydial IFU quantification, phage DNA was detected 3 days
after inoculation and then decreased thereafter and was not
detected after day 9 (Fig. 1B). The early detection of phage
DNA suggested that many of the C. caviae cells probably
became infected very quickly after inoculation into the con-
junctiva or had already been infected in culture. This experi-
ment was repeated with similar results (data not shown).
We next wanted to determine the effect on the infection
course if phage was added to a stock of C. caviae just prior to
inoculation into the animal. There was also some concern that
the C. caviae cells maintained in the Bavoil laboratory that
were used and contained in the C. caviae/phage culture lysate
may differ somewhat in pathogenicity from the C. caviae cells
maintained in the Rank laboratory. Therefore, phage from a
stock containing 106 IFU of C. caviae was treated with chlo-
roform to kill the bacteria and then, after a washing, was
combined with a fresh stock of 106 IFU of C. caviae (Rank
laboratory) (C. caviae plus phage). Hence, the C. caviae con-
tained in the mixture with the phage was from the same source
as the C. caviae inoculated into control animals. This prepara-
tion was inoculated into the conjunctiva as before. Just as in
the animals inoculated with the C. caviae/phage culture lysate,
there was a significant delay (P  0.001) in the time to the
development of the peak pathological response in the conjunc-
tiva (Fig. 2A). Moreover, the degree of response did not attain
the level of the pathology in animals infected with phage-free
C. caviae. Again, there was no pathological response to inoc-
ulation with phage alone. There was also a significant differ-
ence (P  0.001) in the courses of the infection, as measured
by isolation of chlamydiae from the conjunctiva, with chlamyd-
iae in the phage-inoculated group increasing more slowly (Fig.
2B). In this experiment, there was clear demonstration of rep-
lication of the chlamydiaphage in vivo (Fig. 2B). Phage DNA
was present at a low level at 3 days after infection but increased
to a peak level at 6 days and then rapidly declined. The peak
phage activity occurred concomitantly with the peak IFU
count, suggesting that, as the C. caviae population expanded,
so did the phage population. This experiment was repeated as
part of the next experiment (see Fig. 3, C. caviae plus phage,
1:1 group).
Because we arbitrarily chose the relative amounts of C.
caviae and phage in the original stock preparation as the in-
oculum in the first two experiments, we wanted to determine if
the courses of both the chlamydial and phage infections would
be different if we modified the ratio of chlamydiae to phage in
the infection inoculum. Therefore, we inoculated three groups
of five guinea pigs each in the conjunctiva with either a 10:1
ratio of C. caviae IFU to phage (106 IFU C. caviae and a 1:10
dilution of the phage preparation), a 1:10 ratio of C. caviae
IFU to phage (105 IFU C. caviae and undiluted phage), and the
same ratio as in the previous experiments (106 IFU C. caviae
and undiluted phage). Two additional groups of animals were
inoculated with either 105 or 106 IFU of phage-free C. caviae.
The course of the infection was monitored by conjunctival
swabs at 3-day intervals.
The group infected with C. caviae/phage at a 1:1 ratio had a
significantly reduced level of C. caviae (P  0.015) compared
to the group infected with 106 IFU of phage-free C. caviae,
similar to the previous experiments (Fig. 3A). The level of
FIG. 1. Kinetics of C. caviae infection in the guinea pig conjunctiva
and the effect of the presence of CPG1 on (A) the gross pathological
response in the conjunctiva and (B) the course of C. caviae infection
with and without phage. The inoculum was the original C. caviae/phage
culture lysate containing 106 IFU of C. caviae and 51.44 g/ml of VP1
DNA. Each group contains five animals each, and the data points
represent the means of each group except for the pathology scores,
which are the means of both conjunctivas from each animal. The error
bars for the phage DNA represent 1 standard deviation.
FIG. 2. Kinetics of C. caviae infection in the guinea pig conjunctiva
and the effect of the presence of CPG1 on (A) the gross pathological
response in the conjunctiva and (B) the course of C. caviae infection
with and without phage. The inoculum was prepared by adding 106
IFU of C. caviae to purified phage. Each group contains five animals
each, and the data points represent the means of each group except for
the pathology scores, which are the means of both conjunctivas from
each animal. The error bars for the phage DNA represent 1 standard
deviation.
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phage increased concurrently with the chlamydiae and peaked
about 6 days after infection and then declined. When the
amount of phage was decreased (106 IFU phage-free C. caviae
and a 1:10 dilution of the phage stock), no difference was seen
in the course of chlamydial infection compared to that for the
106-IFU control. The level of phage increased more slowly and
reached a peak over 1 log lower than that for the group with
the higher phage inoculum (Fig. 3A).
When the phage-free C. caviae inoculum was decreased to
105 IFU in the presence of undiluted phage (1:10, C. caviae/
phage), the level of phage was similar to that for the 1:1 group
(Fig. 3B). The course of chlamydial infection was significantly
different from that for the control group infected with 105 IFU
phage-free C. caviae (P  0.001). Thus, the ratio of phage to
chlamydiae has significant effects of the course of both phage
and chlamydial infections in the guinea pig conjunctiva.
It was interesting to note that the phage infection generally
decreased and resolved more quickly than the chlamydial in-
fection, although the peak infections of both chlamydiae and
phage occurred at relatively the same time. There have been
ample data published to show that the host immune response,
both antibody and cell-mediated immunity, to C. caviae is
responsible for the decline in chlamydial infection (14), so it is
likely that the clearance of chlamydiae reduces the C. caviae
pool available for phage infection. However, we wanted to
determine whether there was also an immune response to the
phage alone. Terminal sera from the animals, approximately
35 days after infection were evaluated by immunoblot analysis
against the VP1 phage protein to determine if antibody was
elicited. There was only weak antibody to phage detected in a
few of the sera collected from the animals infected in the
conjunctiva with C. caviae and phage (data not shown). While
VP1 is the most abundant phage protein and clearly immuno-
genic (see below), there is really a paucity of information about
the immune response to phage infections in their natural in-
fectious-disease setting. Therefore the possibility that the
phage harbors other strong antigens cannot be excluded. How-
ever, sera collected from two animals inoculated intranasally
with the C. caviae/phage preparation at the same levels as the
stock preparation were strongly positive for antibody to VP1,
demonstrating that the phage was indeed immunogenic. The
apparent lack of an antibody response in the conjunctiva may
be related to inaccessibility of sufficient phage antigen to the
host immune system to be immunogenic.
DISCUSSION
This study marks the first report characterizing the effect of
a phage infection of its obligate intracellular bacterial host in a
local-tissue site in the natural mammalian host of the bacte-
rium. Previous in vitro studies have documented the impact of
phage infection on C. caviae (6, 7). A notable feature of phage-
infected C. caviae is its developmental arrest at the reticulate
body stage accompanied by the appearance of aberrantly en-
larged reticulate bodies similar to forms induced upon a variety
of stresses (e.g., nutrient or iron deprivation or gamma inter-
feron or penicillin treatment). Phage-induced lytic death of
these chlamydiae resulted in immediate lysis of the inclusion
and of the host cell. This dramatic impact of phage infection on
both its prokaryotic and eukaryotic hosts suggested that phage
infection might also provoke an altered pathological outcome.
It appeared that the primary effect of CPG1 infection on the
course of chlamydial infection was in delaying the onset of the
peak level of infection. While the numbers of IFU ultimately
attained by phage-infected cells and controls were the same,
the number of IFU in the early time points was about 2 logs
lower than those at the comparable time point in animals
without phage. A consequence of the early reduction of chla-
mydiae in the conjunctiva was a reduced pathological response,
since the initial acute inflammatory response to chlamydial
infection is to a great extent dependent on the level of chla-
mydiae in the target tissue. Chlamydiae elicit chemokines from
host cells which are essential for the chemotaxis of polymor-
phonuclear leukocytes (PMNs) to the site, resulting in the
pathological response. Any decrease in the number of chla-
mydiae would reduce the chemokine and consequently, the
inflammatory response. We have previously observed that, re-
gardless of the inoculum dose, the peak pathological response
occurs about 5 to 7 days after infection. Decreasing infection
doses merely lower the peak intensity of the pathological re-
sponse (R. G. Rank, unpublished data). This suggests that the
number of chlamydiae present early in the infection is critical
in eliciting the inflammatory response. Thus, phage killing of
FIG. 3. Effect of different ratios of chlamydiae and phage on chla-
mydial infection in the conjunctiva. (A) C. caviae (106 IFU) and puri-
fied phage from the original C. caviae/phage culture lysate or a 1:10
dilution of the purified phage from the lysate were inoculated into the
conjunctiva. (B) C. caviae (105 IFU) and purified phage from the
original phage stock were inoculated into the conjunctiva. Each group
contains five animals each, and the data points represent the means for
each group. The error bars for the phage DNA represent 1 standard
deviation.
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chlamydiae early in the infection could explain the decreased
pathological response. One might speculate that killing of chla-
mydiae by phage may release more chlamydial and cellular
debris and perhaps exacerbate the inflammatory response, but
this does not seem to be the case.
An alternative but equally viable explanation is that, since
phage infection of chlamydiae dramatically alters the physiol-
ogy of the chlamydiae by inhibiting replication and otherwise
disrupting the bacterium and host cell (6), there could be
significant interference with signaling of the host cell by the
organism, thereby reducing the chemokine and cytokine re-
sponse, resulting in a decreased inflammatory response. An
early reduction in the inflammatory response has the added
cascading effect of decreasing the chemokines and cytokines
produced by PMNs because there would be fewer PMNs at the
site. We have observed in vivo in the mouse model of chla-
mydial infection that the chemokine and cytokine response
responsible for acute inflammation at 12 to 24 h after infection
requires viable chlamydiae and is not induced by killed organ-
isms (15). Thus, interference of the phage with normal physi-
ologic pathways and organism interactions with the host cell
could have significant effects on the development of the in-
flammatory response. Nevertheless, the exact mechanism of
the reduced pathological response remains to be determined.
While there are many examples of increased pathogenicity
of bacteria through the introduction of virulence genes by
lysogenic phage, this does not appear to be the case with C.
caviae. Remnants of the phage genome can be detected in the
C. caviae genome, but these are incomplete and nonfunctional
(20). Interestingly, PCR analysis of a DNA sample from the
first passage of the Murray isolate in 1962, which has been
archived in the Rank laboratory, reveals the presence of a
conserved phage sequence in the C. caviae genome (data not
shown), suggesting that phage was indeed associated with C.
caviae in natural infection in guinea pigs. The presence of the
conserved phage sequence in the genome may be the stable
result of multiple ancient recombination events, which at some
stage in C. caviae’s evolution may have served a now long-lost
functional purpose. It is interesting to note that a different
segment of the closely related phage AR39 genome also
exists in the C. pneumoniae genome (11). Thus far, there has
been no evidence for new integration of phage DNA into the
chlamydial genome in in vitro studies. Based on our observa-
tions of reduced pathology in vivo, there does not appear to be
any overt effect of enhancing chlamydial virulence; to the con-
trary, the phage appears to reduce the pathological response by
killing chlamydiae.
An interesting aspect of this study is that the phage infection
is not present for a very long period of time and appears to
resolve more quickly than does the chlamydial infection. Mod-
ifying the dose of phage with respect to C. caviae does not alter
the level and kinetics of the phage and chlamydial infections to
any great extent. The resolution of the phage infection is likely
dependent upon the decreasing numbers of chlamydiae, and in
particular the accessibility of the now-rare elementary bodies
to infectious phage particles. In vitro, it has been observed that
phage gains access to susceptible reticulate bodies within the
intracellular inclusion by first attaching to the extracellular
elementary body (6). In an ongoing chlamydial infection of the
conjunctiva, there is a substantial acute inflammatory re-
sponse, resulting in tissue destruction. Moreover, we have re-
cently observed by transmission electron microscopy that
PMNs appear to facilitate the shedding of infected host cells
from the conjunctival epithelium (17) and that many of these
detached cells still have immature and intact chlamydial inclu-
sions within the cells. We also observed that any elementary
bodies which were not in inclusions had already been phago-
cytized by PMNs. Thus, in the milieu of an ongoing inflamma-
tory response, it may be difficult for phage to “find” and attach
to free elementary bodies. In addition, the intense inflamma-
tory response may be detrimental to the phage itself. Thus, it
is not surprising that the phage infection of C. caviae in vivo is
short-lived.
With this in mind, how then has chlamydiaphage persisted in
nature if its survival is solely dependent upon its association
with C. caviae? If the target tissue of C. caviae is the conjunc-
tiva, it is very clear that the infection resolves in about 3 weeks
and then animals have a high degree of immunity to reinfec-
tion for relatively long periods of time, making a scenario of
continuous animal-to-animal transmission strictly via mechan-
ical transmission of conjunctival secretions unlikely over evo-
lutionary time. Although it has not been confirmed, it is likely
that C. caviae infection, as in most of the other nonprimate
chlamydial infections, is a natural infection of the guinea pig
gut. Murray isolated C. caviae from the eyes of young guinea
pigs but not from mature animals (12), so it is conceivable that
C. caviae also persists in the guts of guinea pigs and only infects
the eye in newborn animals exposed to fecal contaminants. It is
possible that chlamydiae may persist in the gut in the absence
of an inflammatory response. In fact, Igietseme and coworkers
were able to isolate C. muridarum from rectal swabs of mice for
up to 8 months after oral infection but could not demonstrate
a pathological response in the gut (9). Such a situation would
be amenable to the persistence of the chlamydia-phage rela-
tionship in vivo.
Another nonexclusive possible explanation for phage sur-
vival in the face of potent immune responses against itself and
its host chlamydiae is that the phage is readily able to alter its
host specificity through mutation of its coat protein(s). We
previously identified IN5, a surface-exposed 71- to 85-amino-
acid-residue loop of the VP1 major capsid protein, which ap-
pears to mediate host specificity of the chlamydiaphages (19).
The sequence of this segment in CPG1 differs significantly
from that in phages SpV4 and MH2K, which, respectively,
infect Spiroplasma and Bdellovibrio but is relatively conserved
with respect to that in Chp2 and nearly identical to that in
AR39 (one K-to-Q change), which infects C. pneumoniae.
The genomic sequence of CPG1 is in fact virtually identical to
that of the C. pneumoniae phage AR39. Moreover, CPG1
was able to infect C. pneumoniae (the phage-free strain
CWL029) while conversely AR39 was able to infect C. caviae
in in vitro experiments (Hsia and Bavoil, unpublished).
While the guinea pig conjunctiva may not be the natural site
of phage persistence in association with chlamydiae, the
present study does demonstrate that CPG1 can indeed infect
and replicate in C. caviae in the natural animal host for C.
caviae. It does not have any apparent enhancing effect on
chlamydial virulence and may actually be a factor in controlling
a chlamydial population and downregulating the pathological
response at its natural tissue target.
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